前往化源商城

Journal of Pharmaceutical and Biomedical Analysis 2014-11-01

Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.

C Gröer, D Busch, M Patrzyk, K Beyer, A Busemann, C D Heidecke, M Drozdzik, W Siegmund, S Oswald

文献索引:J. Pharm. Biomed. Anal. 100 , 393-401, (2014)

全文:HTML全文

摘要

Cytochrome P450 (CYP) enzymes and UDP-glucuronosyltransferases (UGT) are major determinants in the pharmacokinetics of most drugs on the market. To investigate their impact on intestinal and hepatic drug metabolism, we developed and validated quantification methods for nine CYP (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4 and CYP3A5) and four UGT enzymes (UGT1A1, UGT1A3, UGT2B7 and UGT2B15) that have been shown to be of clinical relevance in human drug metabolism. Protein quantification was performed by targeted proteomics using liquid chromatography with tandem mass spectrometry (LC-MS/MS)-based determination of enzyme specific peptides after tryptic digestion using in each case stable isotope labelled peptides as internal standard. The chromatography of the respective peptides was performed with gradient elution using a reversed phase (C18) column (Ascentis(®) Express Peptide ES-C18, 100mm×2.1mm, 2.7μm) and 0.1% formic acid (FA) as well as acetonitrile with 0.1% FA as mobile phases at a flow rate of 300μl/min. The MS/MS detection of all peptides was done simultaneously with a scheduled multiple reaction monitoring (MRM) method in the positive mode by monitoring in each case three mass transitions per proteospecific peptide and the internal standard. The assays were validated according to current bioanalytical guidelines with respect to specificity, linearity (0.25-50nM), within-day and between-day accuracy and precision, digestion efficiency as well as stability. Finally, the developed method was successfully applied to determine the CYP and UGT protein amount in human liver and intestinal microsomes. The method was shown to possess sufficient specificity, sensitivity, accuracy, precision and stability to quantify clinically relevant human CYP and UGT enzymes. Copyright © 2014 Elsevier B.V. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
甲酸 结构式 甲酸
CAS:64-18-6
蔗糖 结构式 蔗糖
CAS:57-50-1
乙腈 结构式 乙腈
CAS:75-05-8
碘代乙酰胺 结构式 碘代乙酰胺
CAS:144-48-9
碳酸氢铵 结构式 碳酸氢铵
CAS:1066-33-7
氯化钾 结构式 氯化钾
CAS:7447-40-7
苄磺酰氟 结构式 苄磺酰氟
CAS:329-98-6
乙二胺四乙酸 结构式 乙二胺四乙酸
CAS:60-00-4
三羟甲基氨基甲烷盐酸盐 结构式 三羟甲基氨基甲烷盐酸盐
CAS:1185-53-1
β-D-别吡喃糖 结构式 β-D-别吡喃糖
CAS:7283-09-2